Cytomegalovirus induces HLA-class-II-restricted alloreactivity in an acute myeloid leukemia cell line

por Koldehoff, Michael, Lindemann, Monika, Ross, Stefan R., Elmaagacli, Ahmet H.
Publicado 2018

A non-interventional study of the genetic polymorphisms of NOD2 associated with increased mortality in non-alcoholic liver transplant patients

por Saner, Fuat Hakan, Nowak, Knut, Hoyer, Dieter, Rath, Peter, Canbay, Ali, Paul, Andreas, Koldehoff, Michael, Elmaağaclı, Ahmet
Publicado 2014

Molecular characterization of TCF3::PBX1 chromosomal breakpoints in acute lymphoblastic leukemia and their use for measurable residual disease assessment

por Burmeister, Thomas, Gröger, Daniela, Gökbuget, Nicola, Spriewald, Bernd, Starck, Michael, Elmaagacli, Ahmet, Hoelzer, Dieter, Keller, Ulrich, Schwartz, Stefan
Publicado 2023

P674: 2ND-LINE PONATINIB IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA (CML-CP) PATIENTS FAILING OR INTOLERANT TO 1ST-LINE 2ND GENERATION TKI THERAPY: INTERIM ANALYSIS OF THE PROSPECTI...

por Le Coutre, Philipp, Göthert, Joachim, Saussele, Susanne, Pelzer, Uwe, Bullinger, Lars, Elmaagacli, Ahmet, Jehn, Christian, Stegelmann, Frank, Hochhaus, Andreas, Ernst, Thomas, Burchert, Andreas
Publicado 2023

Haploidentical versus unrelated allogeneic stem cell transplantation for relapsed/refractory acute myeloid leukemia: a report on 1578 patients from the Acute Leukemia Working Party...

por Brissot, Eolia, Labopin, Myriam, Ehninger, Gerhard, Stelljes, Matthias, Brecht, Arne, Ganser, Arnold, Tischer, Johanna, Kröger, Nicolaus, Afanasyev, Boris, Finke, Jürgen, Elmaagacli, Ahmet, Einsele, Herman, Mohty, Mohamad, Nagler, Arnon
Publicado 2019

Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf...

por Ruggeri, Annalisa, Labopin, Myriam, Bacigalupo, Andrea, Afanasyev, Boris, Cornelissen, Jan J., Elmaagacli, Ahmet, Itälä-Remes, Maija, Blaise, Didier, Meijer, Ellen, Koc, Yener, Milpied, Noel, Schouten, Harry C., Kroeger, Nicolaus, Mohty, Mohamad, Nagler, Arnon
Publicado 2018

General condition and comorbidity of long-term survivors of adult acute lymphoblastic leukemia

por Gökbuget, Nicola, Ihrig, Kristina, Stadler, Michael, Stelljes, Matthias, Elmaagacli, Ahmet, Starck, Michael, Raffel, Simon, Stoltefuss, Andrea, Viardot, Andreas, Kreuzer, Karl-Anton, Heidenreich, Daniela, Renzelmann, Andrea, Wäsch, Ralph, Topp, Max S., Ritter, Barbara, Reimer, Peter, Beck, Joachim, Westermann, Jörg, Wendelin, Knut, Alakel, Nael, Hanoun, Maher, Serve, Hubert, Hoelzer, Dieter
Publicado 2023

Association of Country-Specific Socioeconomic Factors With Survival of Patients Who Experience Severe Classic Acute Graft-vs.-Host Disease After Allogeneic Hematopoietic Cell Trans...

por Frankiewicz, Andrzej, Peczynski, Christophe, Giebel, Sebastian, Harrington, Alenca, Socié, Gerard, Niederwieser, Dietger, Scheid, Christoph, Bornhäuser, Martin, Kröger, Nicolaus, Elmaagacli, Ahmet, Afanasyev, Boris, Dreger, Peter, Rössig, Claudia, Blaise, Didier, Kratz, Christian, Yakoub-Agha, Ibrahim, Kremens, Bernhard, Niemeyer, Charlotte Marie, Wulf, Gerald, Blau, Igor, Penack, Olaf, Greinix, Hildegard, Basak, Grzegorz W.
Publicado 2020

Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age

por Mai, Elias K., Miah, Kaya, Bertsch, Uta, Dürig, Jan, Scheid, Christof, Weisel, Katja C., Kunz, Christina, Munder, Markus, Lindemann, Hans-Walter, Merz, Maximilian, Hose, Dirk, Jauch, Anna, Seckinger, Anja, Luntz, Steffen, Sauer, Sandra, Fuhrmann, Stephan, Brossart, Peter, Elmaagacli, Ahmet, Goerner, Martin, Bernhard, Helga, Hoffmann, Martin, Raab, Marc S., Blau, Igor W., Hänel, Mathias, Benner, Axel, Salwender, Hans J., Goldschmidt, Hartmut
Publicado 2020

Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial

por Klein, Eva-Maria, Tichy, Diana, Salwender, Hans J., Mai, Elias K., Duerig, Jan, Weisel, Katja C., Benner, Axel, Bertsch, Uta, Akhavanpoor, Mabast, Besemer, Britta, Munder, Markus, Lindemann, Hans-Walter, Hose, Dirk, Seckinger, Anja, Luntz, Steffen, Jauch, Anna, Elmaagacli, Ahmet, Fuhrmann, Stephan, Brossart, Peter, Goerner, Martin, Bernhard, Helga, Raab, Marc S., Blau, Igor W., Haenel, Mathias, Scheid, Christof, Goldschmidt, Hartmut
Publicado 2021

Publisher Correction: Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age

por Mai, Elias K., Miah, Kaya, Bertsch, Uta, Dürig, Jan, Scheid, Christof, Weisel, Katja C., Kunz, Christina, Munder, Markus, Lindemann, Hans-Walter, Merz, Maximilian, Hose, Dirk, Jauch, Anna, Seckinger, Anja, Luntz, Steffen, Sauer, Sandra, Fuhrmann, Stephan, Brossart, Peter, Elmaagacli, Ahmet, Goerner, Martin, Bernhard, Helga, Hoffmann, Martin, Raab, Marc S., Blau, Igor W., Hänel, Mathias, Benner, Axel, Salwender, Hans J., Goldschmidt, Hartmut
Publicado 2021